| Term 
 | Definition 
 
        | 
 
ProzacSSRILong t1/2Dose: 20-60mg per dayActivatingAE: HA, stomach upset, weight loss/gain, sexual dysfunctionPrimarily inhibits CYP450 2D6, 3A3/3A4 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
ZoloftSSRIIntermediate t1/2ActivatingP450 2C and 2D6 (inhibitor)Withdrawal symptomsMay require doses up to 200mg/daySE: GI, agitation, insomnia, sexual dysfunction, weight neutral (?)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
PaxilSSRIIntermediate t1/2Dose 20-60mg/dayLeast activatingPotent CYP 2D6 inhibitorMild anticholinergic symptomsWithdrawal symptomsAvoid in hypersomnia, motor retardationIncrease in major congenital malformations compared to other antidepressants   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
CelexaS- and R-isomersDose: 20-60mg/dayHighly selective SSRIInhibitor of 3A4, weak inhibitor of 2D6Less sexual dysfunction?WithdrawalAvoid in agitation and sleep disturbance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
LuvoxSSRILong t1/2Dose: 50-300mg/dayWithdrawal syndromeGI adverse eventsInhibits CYP 1A2, 2C19, and 3A4AE: GI (N/V), agitation, insomnia, and sexual dysfunction   |  | 
        |  | 
        
        | Term 
 
        | Venlafaxine/Desvenlafaxine |  | Definition 
 
        | 
 
EffexorSNRIMixed 5HT-NE reuptake inhibitorShort t1/2= given bidDose: 37.5-225mg/dayMay cause dose related hypertensionLow potency 2D6 inhibitor, low incidence of drug interactionMay be more dangerous in overdose situations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
CymbaltaPK-Tmax 6hrs, t1/2 15hrsMetabolized by hydroxylation CYP2D6 and CYP1A2Dose: 30-90+mg/dayModerate inhibitor of 2D6. Levels increased by medications that inhibit 1A2 and 2D6AE: Nausea, dry moutlh, constipation, insomnia, dizzinessMay help in treatment of diabetic neuropathy   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
DesyrelMixed selective serotonin reuptake inhibitor & receptor blockersGood for sleepPossible serotonin  syndrome when combined with SSRIs, MAOIsDizziness, sedation, and cognitivie slowing are dose relatedNefazodone may cause hepatic failure (black box warning); 3A4 
3A4 inhibitor-DI with BZDs; Ritonavir   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
 Wellbutrin, ZybanMixed reuptake inhibitorImmediate release-bid or tid dosing 
Controlled release (SR) is given bid, but may be given daily in doses <200mgExtended release (XL) is given daily in doses <450mgMay lower seizure threshold (DI with antiepileptics); Ritonavir (↑Bupropion levels)AE: agitation, nausea, insomnia, psychosis, dose related seizuresNo known withdrawalLess sexual dysfunction   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
RemeronMixed selective serotonin reuptake inhibitor & receptor blockersHistaminic properties-sedating at lower doses, less at higher dosesAnxiolyticWeight gainMetabolized by: 2D6, 1A2, 3A4,2C9Few drug interactions   |  | 
        |  |